DSRU Scientific Publications
Use our keyword search facility to match our publications with your area of interest.
253 publications found, showing 1 to 20
-
Systematic reviews of adverse effects of drug interventions: a survey of their conduct and reporting quality.
Cornelius VR, Perrio MJ, Shakir SA, Smith LA.
Pharmacoepidemiol Drug Saf. September 2009 -
Strontium ranelate as a cause of acute renal failure and dress syndrome.
Iyer D, Buggy Y, O'Reilly K, Searle M
Nephrology September 2009 -
Safety Profile of Varenicline as used in General Practice in England: Interim Results from a Prescription-Event Monitoring Study
Kasliwal R, Wilton L, Shakir S
Drug Saf. June 2009 -
Hypoglycaemia with anti-diabetic drugs: Results from Prescription-Event Monitoring cohorts of rosiglitazone, pioglitazone, nateglinide and repaglinide
Vickova V, Cornelius V, Kasliwal R, Wilton L, Shakir S
Drug Saf. May 2009 -
Risk management and outcomes of adverse events to Pioglitazone in Primary Care in the UK; an observational study
Fogg C, Kasliwal R, Shakir SA.
Drug Saf. March 2009 -
The safety profile of tadalafil as prescribed in general practice in England: results from a prescription-event monitoring study involving 16 129 patients.
Hazell L, Cornelius V, Wilton LV, Shakir SA.
BJU Int. February 2009 -
Examining the tolerability of the non-sedating antihistamine desloratadine: a prescription-event monitoring study in England
Layton D, Wilton L, Shakir S
Drug Saf. February 2009 -
Antipsychotics and stroke: the story to date.
Layton D, Cox A.
The Pharmaceutical Journal. January 2009 -
Neuraminidase inhibitors: widespread use for influenza may reveal more adverse effects
Layton D, Cox A
The Pharmaceutical Journal. January 2009 -
Pattern of drug utilisation for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy
Dodoo AN, Fogg C, Asiimwe A, Nartey ET, Kodua A, Tenkorang O, Ofori-Adjei D
Malar J. January 2009 -
Use and risk management of Carvedilol for the treatment of heart failure in the community in England: results from a modified prescription-event monitoring study
Aurich-Barrera B, Wilton LV, Shakir SA
Drug Saf. January 2009 -
Prescriber adoption of newly approved selective COX-2 inhibitors.
Layton D, Souverein PC, Heerdink ER, Shakir SA, Egberts AG.
Pharmacoepidemiol Drug Saf. December 2008 -
Monitoring the safety of pioglitazone : results of a prescription-event monitoring study of 12,772 patients in England.
Kasliwal R, Wilton LV, Shakir SA.
Drug Saf. October 2008 -
Adverse drug reactions: Neuropsychiatric drug reactions associated with varenicline (Champix).
Layton D and Cox A.
The Pharmaceutical Journal. June 2008 -
Developing tools for the safety specification in risk management plans: lessons learned from a pilot project.
Cooper AJ, Lettis S, Chapman CL, Evans SJ, Waller PC, Shakir S, Payvandi N, Murray AB.
Pharmacoepidemiol Drug Saf. May 2008 -
Prescription Event Monitoring in the United Kingdom
Shakir SAW
Pharmacoepidemiology and Therapeutic Risk Management. April 2008 -
European commission consultation on pharmacovigilance
Waller P, Beard K, Egberts T, Evans S, Hallas J, Hasford J, Laporte JR, Moore N, Shakir S, Sturkenboom M.
Pharmacoepidemiol Drug Saf. February 2008 -
Safety profile of esomeprazole : results of a prescription-event monitoring study of 11 595 patients in England.
Davies M, Wilton LV, Shakir SA.
Drug Saf. January 2008 -
Evaluation of risk profiles for gastrointestinal and cardiovascular adverse effects in nonselective NSAID and COX-2 inhibitor users: a cohort study using pharmacy dispensing data in The Netherlands.
Layton D, Souverein PC, Heerdink ER, Shakir SA, Egberts AC.
Drug Saf. January 2008 -
The safety profiles of orlistat and sibutramine: results of prescription-event monitoring studies in England.
Perrio MJ, Wilton LV, Shakir SA.
Obesity. December 2007